NCT05898308View on ClinicalTrials.gov

Comparison of a Personalized Maintenance Therapy With the Standard Treatment in Pemphigus

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

133

Participants

Timeline

Start Date

September 1, 2023

Primary Completion Date

March 1, 2027

Study Completion Date

July 1, 2031

Conditions
PemphigusDermatologic Disease
Interventions
DRUG

RiTUXimab Injection

"Patients assigned to the personalized maintenance treatment will be treated by additional RITUXIMAB injection depending on anti-Dsg Abs levels."

All Listed Sponsors
lead

University Hospital, Rouen

OTHER

NCT05898308 - Comparison of a Personalized Maintenance Therapy With the Standard Treatment in Pemphigus | Biotech Hunter | Biotech Hunter